Patents 237show all

  • 128
    C07K - Peptides
  • 123
    A61K - Preparations for medical, dental, or toilet purposes
  • 57
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 28
    C12N - Microorganisms or enzymes
  • 27
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 10
    Y02A - Technologies for adaptation to climate change
  • 9
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 2
    A01K - Animal husbandry
  • 2
    B82Y - Specific uses or applications of nanostructures
  • 1
    G06N - Computer systems based on specific computational models

Clinical Trials 35show all

24Phase 17Phase 22N/A2Phase 1/Phase 2

SEC Filings show all


53
8-K

17
10-Q

6
10-K

2
D

1
S-1

Contact Information

Redwood City, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2013-12-06$22,249,996$22,249,996Equity
2009-02-23Unknown Unknown Other (Paper Filing)

Key Executives

  • Paul J. Hastings
    Executive Officer, Director
  • William D. Waddill
    Executive Officer
  • John A. Lewicki
    Executive Officer
  • Sunil Patel
    Executive Officer
  • Jakob Dupont
    Executive Officer
  • Alicia J. Hager
    Executive Officer
  • Timothy Hoey
    Executive Officer
  • Austin Gurney
    Executive Officer
  • Jim Woody
    Director
  • James Broderick
    Director
  • Terry Gould
    Director
  • Jack Lasersohn
    Director
  • Larry Lasky
    Director
  • Deepa Pakianathan
    Director
  • Denise Pollard-Knight
    Director
  • Jonathan Root
    Director
  • Michael Wyzga
    Director